Asia PR News

SYDNEY, March 30 /AsiaNet/ –

CHILDHOOD DISEASES…
KUALA LUMPUR: The deadly diseases pneumonia and meningitis
kill an estimated 1.8 million children under the age of 5 years
across the globe every year. Of these, more than 700,000 occur
in the countries in the South-East Asia and Western Pacific
regions of the World Health Organization. Experts are meeting
in Malaysia to focus on two particularly concerning
vaccine-preventable causes of pneumonia and meningitis: the
bacteria Haemophilus influenzae type B and Streptococcus
pneumoniae.
http://www.preventpneumo.org
http://www.HibAction.org

PEPSICO EARNINGS…
PURCHASE, N.Y.: PepsiCo, Inc. has announced that its
first-quarter 2006 earnings conference call and slide
presentation for financial analysts and investors will be
webcast live over the internet on Wednesday, April 26, at 11
a.m. (ET).
http://www.pepsico.com

ENERGY-FRIENDLY BUILDINGS…
GENEVA: The World Business Council for Sustainable
Development announced that it is forming an alliance of leading
global companies to determine how buildings can be designed and
constructed so that they use no energy from external power
grids, are carbon neutral, and can be built and operated at
fair market values.

QUINTILES JAPAN…
RESEARCH TRIANGLE PARK, N.C.: Quintiles Transnational Corp.
has announced the appointment of Yoh Narimatsu as President and
Chief Executive Officer of Quintiles Transnational Japan K.K.
(Quintiles Japan) effective April 1. Narimatsu, who has more
than 30 years of international business experience, will lead
all operations of Quintiles Japan.
http://www.quintiles.com

CHINA OFFICE…
SHANGHAI: Citigroup opened its first Private Bank office in
mainland China at a ceremony at Citigroup Tower attended by
Todd Thomson, Chairman & Chief Executive Officer of Citigroup
Global Wealth Management.
www.citigroup.com
http://xprnnews.xfn.info/Citigroup/CitigroupPhoto3.htm

PRELIMINARY RESULTS…
LUND, Sweden: AstraZeneca has welcomed preliminary results
from the TORCH (TOwards a Revolution in COPD Health) study,
suggesting combination therapies containing an inhaled
corticosteroid and long-acting beta 2 agonist have the
potential to show mortality benefits for COPD patients.

AsiaNet is a consortium of leading news agencies
distributing unedited, translated news releases for worldwide
clients. Visit www.asianetnews.net for full-text versions.